We are Sorry, This Page doesn't Exist

Teva's (TEVA) shares rally as it enters into an agreement to settle all patent litigation related to its abbreviated new drug application for Neos Therapeutics' ADHD drug, Cot.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Shares of Heron Therapeutics Inc. gained 3.0% in trading on Thursday after the company said the Food and Drug Administration had approved its non-opioid anesthetic for use in some surgical patients. The drug, Zynrelef, is expected to bec.....»»

GlaxoSmithKline PLC and Vir Biotechnology Inc. said Friday they have submitted to the U.S. Food and Drug Administration an application for emergency use authorization for their antibody treatment for mild-to-moderate COVID-19 in adults and adolesce.....»»

PLx Pharma Inc (NASDAQ: PLXP) shares we.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Osmotica Pharmaceuticals (NASDAQ: OSMT) shares were trading higher Monday in anticipation of a ruling by the FDA on the company's New Drug Application for Arbaclofen ER in patients with multiple sclerosis. read more.....»»

Zealand Pharma files New Drug Application with U.S. FDA for dasiglucagon HypoPal® rescue pen, secures DKK 137 million in additional investment, and .....»»

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) has finally made progress in its squabble with regulators. The D.C. biotech announced Wednesday it can now resubmit its application to the Food and Drug Administration for Hetlioz, its product for non-24-h.....»»

GW Pharmaceuticals PLC shares rose 2.6% in the extended session Monday after the U.K.-based company sold much more of its cannabis derived epilepsy d.....»»

–Submitted investigational new drug (IND) application for a Phase 2 trial of EDP1815 for COVID-19; data readout expected during.....»»

Moderna Inc. said late Monday its candidate for a coronavirus vaccine will get to be evaluated further. The biotech company said it has submitted a new-drug application with the U.S. Food and Drug Administration to evaluate.....»»

BioSig Technology (NASDAQ: BSGM) shares are trading higher on Friday after the company's subsidiary VirtalClear submitted an investigational new drug application to the FDA for a Phase 2 clinical trial of Merimepodib. read more.....»»

Although nearly 1.7 million PPP loans have been approved so far, a survey found that 80% of small businesses are either still waiting to receive their money or have not heard about their application at all. Four major banks are facing lawsuits allegin.....»»

Alzheimer’s disease patients will have to wait a little longer for Biogen’s new drug, which is now expected to be submitted for FDA approval in the fall.  Biogen (Nasdaq: BIIB) previously told investors during during a January earnings call that i.....»»

Shares of Laboratory Corporation of America Holdings gained 5% in premarket trading on Tuesday after the company announced it received an emergency use authorization from the Food and Drug Administration to market an at-home COVI.....»»